MedTrace Logo

PinPointe FootLaser for the Treatment of Onychomycosis

NCT00935649 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2013-04-09

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and efficacy of the PathoLase FootLaser treatment of infected toenails.

Conditions

  • Infected Toenails
  • Onychomycosis

Interventions

DEVICE

PinPointe FootLaser

Medical laser

Sponsors & Collaborators

  • PathoLase, Inc.

    lead INDUSTRY

Principal Investigators

  • David M Harris, PhD · PathoLase, Inc.

  • Bernard Goffe, MD · Dermatology Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935649 on ClinicalTrials.gov